HtrA Serine Peptidase 2 (HTRA2) (Middle Region) Peptide
HTRA2
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN5511273
Aperçu rapide pour HtrA Serine Peptidase 2 (HTRA2) (Middle Region) Peptide (ABIN5511273)
Antigène
HTRA2
(HtrA Serine Peptidase 2 (HTRA2))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Séquence
- TMKVTAGISF AIPSDRLREF LHRGEKKNSS SGISGSQRRY IGVMMLTLSP
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-HTRA2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- HTRA2 (HtrA Serine Peptidase 2 (HTRA2))
-
Sujet
-
This gene encodes a serine protease. The protein has been localized in the endoplasmic reticulum and interacts with an alternatively spliced form of mitogen-activated protein kinase 14. The protein has also been localized to the mitochondria with release to the cytosol following apoptotic stimulus. The protein is thought to induce apoptosis by binding the apoptosis inhibitory protein baculoviral IAP repeat-containing 4. Nuclear localization of this protein has also been observed. Alternate splicing of this gene results in two transcript variants encoding different isoforms. Additional transcript variants have been described, but their full-length sequences have not been determined.
Alias Symbols: OMI, PARK13, PRSS25
Protein Size: 361 -
ID gène
- 27429
-
NCBI Accession
- NM_013247, NP_037379
Antigène
-
Vous êtes ici:
